CDC hosts a public meeting with representatives from the U.S. Food and Drug Administration (FDA), NIH, the blood services community, gay activists, and hemophilia specialists to identify opportunities to protect the nation’s blood supply from AIDS. Yet participants fail to reach consensus on appropriate action.